Primary assessment of the diversity of Omicron sublineages and the epidemiologic features of autumn/winter 2022 COVID-19 wave in Chinese mainland

[1]  Feng Liu,et al.  Host protection against Omicron BA.2.2 sublineages by prior vaccination in spring 2022 COVID-19 outbreak in Shanghai , 2023, Frontiers of Medicine.

[2]  Q. Zhang,et al.  VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19 , 2022, New England Journal of Medicine.

[3]  Geng Wu,et al.  Mathematical appraisal of SARS-CoV-2 Omicron epidemic outbreak in unprecedented Shanghai lockdown , 2022, Frontiers in Medicine.

[4]  Zhaohui Qian,et al.  Relative vaccine effectiveness against Delta and Omicron COVID-19 after homologous inactivated vaccine boosting: a retrospective cohort study , 2022, BMJ Open.

[5]  Peng Wang,et al.  Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution , 2022, bioRxiv.

[6]  A. Frigessi,et al.  Increased household transmission and immune escape of the SARS-CoV-2 Omicron compared to Delta variants , 2022, Nature Communications.

[7]  Xinxin Zhang,et al.  The Omicron BA.2.2.1 subvariant drove the wave of SARS-CoV-2 outbreak in Shanghai during spring 2022 , 2022, Cell Discovery.

[8]  P. Austin,et al.  Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes , 2022, JAMA network open.

[9]  A. Cook,et al.  Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore , 2022, JAMA network open.

[10]  R. Bull,et al.  Evolution of the SARS‐CoV‐2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission , 2022, Reviews in medical virology.

[11]  Fei Shao,et al.  BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection , 2022, Nature.

[12]  G. Bálint,et al.  Omicron: increased transmissibility and decreased pathogenicity , 2022, Signal Transduction and Targeted Therapy.

[13]  Wenhong Zhang,et al.  Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic , 2022, The Lancet.

[14]  A. Katzourakis,et al.  Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity , 2022, Nature Reviews Microbiology.

[15]  Wenhong Zhang,et al.  SARS-CoV-2 variants, immune escape, and countermeasures , 2022, Frontiers of Medicine.

[16]  M. Baniecki,et al.  Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 , 2022, The New England journal of medicine.

[17]  K. Leung,et al.  Waning antibody levels after COVID-19 vaccination with mRNA Comirnaty and inactivated CoronaVac vaccines in blood donors, Hong Kong, April 2020 to October 2021 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[18]  S. Madhi,et al.  COVID-19 vaccine strategies must focus on severe disease and global equity , 2021, The Lancet.

[19]  Fei Shao,et al.  Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies , 2021, bioRxiv.

[20]  O. Pybus,et al.  Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool , 2021, Virus evolution.

[21]  Yixiao Lin,et al.  Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection , 2020, Frontiers of Medicine.

[22]  W. Wang,et al.  Viral and host factors related to the clinical outcome of COVID-19 , 2020, Nature.

[23]  W. Wang,et al.  Viral and host factors related to the clinical outcome of COVID-19 , 2020, Nature.

[24]  Jennifer Lu,et al.  Improved metagenomic analysis with Kraken 2 , 2019, Genome Biology.

[25]  Jia Gu,et al.  fastp: an ultra-fast all-in-one FASTQ preprocessor , 2018, bioRxiv.

[26]  Trevor Bedford,et al.  Nextstrain: real-time tracking of pathogen evolution , 2017, bioRxiv.

[27]  Paolo Di Tommaso,et al.  Nextflow enables reproducible computational workflows , 2017, Nature Biotechnology.